Dermatomyositis ‐lupus overlap syndrome complicated with cardiomyopathy after SARS‐CoV‐2 infection: A new potential trigger for musculoskeletal autoimmune disease development

COVID-19  should be considered as a new triggering factor for autoimmune disorders like DM-lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID-19. AbstractCOVID-19  should be considered as a new triggering factor for autoimmune disorders like DM-lupus overlap syndrome. We recommend that patients presenting with dermatomyositis during this pandemic be screened for COVID-19.

Source: Clinical Case Reports - October 13, 2021 Category: General Medicine Authors: Mohammad Shahidi Dadras, Azadeh Rakhshan, Arman Ahmadzadeh, Seyed Ali Hosseini, Reem Diab, Toktam Safari Giv, Fahimeh Abdollahimajd Tags: CASE REPORT Source Type: research